stockrowSarepta Therapeutics, Inc.
SRPT Healthcare Biotechnology
Sarepta Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 15.6% from fiscal 2024.
- Revenue
- −4.51%
- EPS
- +46.0%
- Free cash flow
- +231.8%
- Total debt
- −17.2%
Quarter to September 2026, against a year earlier
Follow SRPT
Alert me
Sarepta Therapeutics, Inc. (SRPT) Revenue growth
Sarepta Therapeutics, Inc.'s revenue growth over the twelve months to 30 September 2026 was −19.0%, down 34.5 percentage points from fiscal 2025 (15.6%). Over the past ten years it has ranged from −87.2% (fiscal 2015) to 2,751.6% (fiscal 2017); the current reading is higher than 18% of that period. That is below the Biotechnology industry median of 6.76% and below the Healthcare sector median of 7.98%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 15.6% | (37.39) |
| FY2024 | 53.0% | 19.71 |
| FY2023 | 33.3% | 0.33 |
| FY2022 | 32.9% | 2.97 |
| FY2021 | 30.0% | (11.86) |
| FY2020 | 41.8% | 15.31 |
| FY2019 | 26.5% | (68.23) |
| FY2018 | 94.7% | (2,656.84) |
| FY2017 | 2,751.6% | 2,418.94 |
| FY2016 | 332.6% | 419.80 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | −4.51% | 29.83 |
| Jun 2026 | −34.3% | (32.45) |
| Mar 2026 | −1.89% | 30.84 |
| Dec 2025 | −32.7% | (18.21) |
| 35 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| VIR Vir Biotechnology, Inc. compare | 1,696.0% |
| HRMY Harmony Biosciences Holdings, Inc. compare | 19.8% |
| MRVI Maravai LifeSciences Holdings, Inc. compare | 10.7% |
| SRPT Sarepta Therapeutics, Inc. | −19.0% |
| MESO Mesoblast Limited compare | −26.5% |
| TRVI Trevi Therapeutics, Inc. compare | — |
| MAZE Maze Therapeutics, Inc. compare | — |
| TRAX First Tracks Biotherapeutics, Inc. compare | — |
| REPL Replimune Group, Inc. compare | — |
| Biotechnology industry median | 6.76% |
| Healthcare sector median | 7.98% |
| Market median | 7.71% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|